Kees Roks is the Head of the European Oncology Business at Novartis Pharma, Switzerland. Since November 2018 he is responsible for leading over 2000 dedicated associates in 51 countries on the journey to reimagine medicines.
His Novartis career started in 1985 in the Netherlands. Since then he has held various roles of increasing responsibility in several international markets and cultures from Europe to Latin America and even as far away as Japan.
Each move has given him a greater perspective on why access, affordability, and accessibility to care are now more critical than ever. Beyond his professional career, he is a member of the EFPIA Patient Access Committee. He is part of the Assembly for the EU Cancer Mission and is a member of the Scientific Advisory Board for the Open Research Europe initiative, both for the European Commission.
Kees studied Medical Microbiology and holds a degree in Business Administration from the University of Eindhoven, Netherlands.